SCM
IART icon

Sterling Capital Management’s Integra LifeSciences IART Stock Holding History

Sterling Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.1K Sell
2,235
-1,650
-42% -$18.1K ﹤0.01% 2007
2025
Q4 		$48.3K Sell
3,885
-743
-16% -$9.88K ﹤0.01% 1816
2025
Q3 		$66.3K Buy
4,628
+2,815
+155% +$38.6K ﹤0.01% 1671
2025
Q2 		$22.2K Buy
1,813
+646
+55% +$9.38K ﹤0.01% 1755
2025
Q1 		$25.7K Sell
1,167
-999
-46% -$23.5K ﹤0.01% 1591
2024
Q4 		$49.1K Buy
2,166
+1,931
+822% +$42.1K ﹤0.01% 1615
2024
Q3 		$4.27K Buy
+235
New +$5.45K ﹤0.01% 1823

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sterling Capital Management's IART Position: Q1 2026 in Review

Sterling Capital Management reduced its Integra LifeSciences (IART) stake by 42% in Q1 2026, selling an estimated $18.1K and leaving 2,235 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2007.

Sterling Capital Management first reported a position in IART in Q3 2024 and has held it in 7 quarters since. The position peaked at $66.3K in Q3 2025. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Sterling Capital Management held 2,235 shares of Integra LifeSciences worth $21.1K as of Q1 2026.
  • Sterling Capital Management sold 1,650 Integra LifeSciences shares in Q1 2026, an estimated $18.1K.
  • Integra LifeSciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2007 holding.
  • Sterling Capital Management first reported a position in Integra LifeSciences in Q3 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's Integra LifeSciences position peaked at $66.3K in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.